Lionel Pinto

1.5k total citations
33 papers, 1.2k citations indexed

About

Lionel Pinto is a scholar working on Surgery, Economics and Econometrics and Immunology. According to data from OpenAlex, Lionel Pinto has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Economics and Econometrics and 7 papers in Immunology. Recurrent topics in Lionel Pinto's work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Lipoproteins and Cardiovascular Health (6 papers) and Psoriasis: Treatment and Pathogenesis (6 papers). Lionel Pinto is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (8 papers), Lipoproteins and Cardiovascular Health (6 papers) and Psoriasis: Treatment and Pathogenesis (6 papers). Lionel Pinto collaborates with scholars based in United States, United Kingdom and Canada. Lionel Pinto's co-authors include Quan V. Doan, James Trussell, Amber Trujillo Lalla, Eileen Reyes, Joseph Gricar, Hema N. Viswanathan, Robert W. Dubois, Jalpa A. Doshi, Junko Takeshita and Richard Barron and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Lionel Pinto

30 papers receiving 1.1k citations

Peers

Lionel Pinto
Randall S. Krakauer United States
Maurice G. Rüssel Netherlands
June‐Ho Kim United States
Amanda Golembesky United States
Bruce V. Stadel United States
Rajiv Mallick United States
Fiona L. Dignan United Kingdom
Anthony D. Sung United States
Randall S. Krakauer United States
Lionel Pinto
Citations per year, relative to Lionel Pinto Lionel Pinto (= 1×) peers Randall S. Krakauer

Countries citing papers authored by Lionel Pinto

Since Specialization
Citations

This map shows the geographic impact of Lionel Pinto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lionel Pinto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lionel Pinto more than expected).

Fields of papers citing papers by Lionel Pinto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lionel Pinto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lionel Pinto. The network helps show where Lionel Pinto may publish in the future.

Co-authorship network of co-authors of Lionel Pinto

This figure shows the co-authorship network connecting the top 25 collaborators of Lionel Pinto. A scholar is included among the top collaborators of Lionel Pinto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lionel Pinto. Lionel Pinto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jain, Mahim, et al.. (2025). High clinical burden of classical homocystinuria in the United States: a retrospective analysis. Orphanet Journal of Rare Diseases. 20(1). 37–37.
2.
Pokrzywinski, Robin, et al.. (2025). “My dream is to not have to be on a diet”: a qualitative study on burdens of classical homocystinuria (HCU) from the patient perspective. Orphanet Journal of Rare Diseases. 20(1). 106–106. 1 indexed citations
3.
Jain, Mahim, et al.. (2024). Estimating prevalence of classical homocystinuria in the United States using Optum's de-identified market clarity data. Molecular Genetics and Metabolism Reports. 40. 101101–101101.
4.
Pinto, Lionel, et al.. (2024). Association between homocysteine and clinical outcomes in patients with classical homocystinuria: A systematic literature review. Molecular Genetics and Metabolism. 141(4). 108244–108244. 1 indexed citations
5.
6.
Kuo, Yu-Lun, et al.. (2021). PCV17 Cost Analysis of Myocardial Infarction and Ischemic Stroke Using the National Claims Database in Taiwan. Value in Health. 24. S69–S69. 1 indexed citations
7.
Chen, Guanmin, et al.. (2020). LIPID-LOWERING THERAPY PATTERNS AND LOW-DENSITY LIPOPROTEIN-CHOLESTEROL MANAGEMENT AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION IN ALBERTA, CANADA. Journal of the American College of Cardiology. 75(11). 44–44. 1 indexed citations
8.
Matza, Louis S., John Brazier, Katie D. Stewart, et al.. (2019). Developing a preference-based utility scoring algorithm for the Psoriasis Area Severity Index (PASI). Journal of Medical Economics. 22(9). 936–944. 8 indexed citations
9.
Fujiwara, Saeko, Akimitsu Miyauchi, Adèle Weston, et al.. (2018). Treatment patterns in patients with osteoporosis at high risk of fracture in Japan: retrospective chart review. Archives of Osteoporosis. 13(1). 34–34. 19 indexed citations
10.
Guo, Haifeng, et al.. (2018). Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis. Osteoporosis International. 29(11). 2409–2417. 20 indexed citations
11.
Fischer, Shira H., Kandice A. Kapinos, Andrew Mulcahy, et al.. (2017). Estimating the long-term functional burden of osteoporosis-related fractures. Osteoporosis International. 28(10). 2843–2851. 40 indexed citations
12.
Doshi, Jalpa A., Junko Takeshita, Lionel Pinto, et al.. (2016). Biologic therapy adherence, discontinuation, switching, and restarting among patients with psoriasis in the US Medicare population. Journal of the American Academy of Dermatology. 74(6). 1057–1065.e4. 98 indexed citations
13.
Strober, Bruce, Kim Papp, Mark Lebwohl, et al.. (2016). Clinical meaningfulness of complete skin clearance in psoriasis. Journal of the American Academy of Dermatology. 75(1). 77–82.e7. 93 indexed citations
14.
Doshi, Jalpa A., et al.. (2015). Biologic Adherence among Psoriasis Patients in the us Medicare Population. Value in Health. 18(3). A186–A186. 2 indexed citations
15.
Takeshita, Junko, Joel M. Gelfand, Lionel Pinto, et al.. (2015). Psoriasis in the US Medicare Population: Prevalence, Treatment, and Factors Associated with Biologic Use. Journal of Investigative Dermatology. 135(12). 2955–2963. 113 indexed citations
16.
Feldman, Steven R., Donald M. Bushnell, Paul Klekotka, et al.. (2015). Differences in psoriasis signs and symptom severity between patients with clear and almost clear skin in clinical practice. Journal of Dermatological Treatment. 27(3). 224–227. 20 indexed citations
17.
Messerli, Franz H., Lionel Pinto, Simon Tang, et al.. (2008). Impact of Systemic Hypertension on the Cardiovascular Benefits of Statin Therapy—A Meta-Analysis. The American Journal of Cardiology. 101(3). 319–325. 31 indexed citations
18.
Pinto, Lionel, Zhimei Liu, Quan V. Doan, et al.. (2007). Comparison of pegfilgrastim with filgrastim on febrile neutropenia, grade IV neutropenia and bone pain: a meta-analysis of randomized controlled trials. Current Medical Research and Opinion. 23(9). 2283–2295. 134 indexed citations
19.
Stempel, David A., Lionel Pinto, & Richard H. Stanford. (2002). The risk of hospitalization in patients with asthma switched from an inhaled corticosteroid to a leukotriene receptor antagonist. Journal of Allergy and Clinical Immunology. 110(1). 39–41. 20 indexed citations
20.
Li, Zhiming, Richard J. Willke, Lionel Pinto, et al.. (2001). Comparison of Length of Hospital Stay for Patients with Known or Suspected Methicillin‐Resistant Staphylococcus Species Infections Treated with Linezolid or Vancomycin: A Randomized, Multicenter Trial. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(3). 263–274. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026